Global Antibiotic Research and Development Partnership
room 15 Chemin Camille-Vidart | 1202 Geneva | Switzerland
arrow_back See all Activities

Serious Bacterial Infections

IATI Identifier: CH-FDJP-CHE331930936-SBI-21

Published on IATI
  • date_range Jan 01, 2020
  • autorenew Implementation (Status)

Serious bacterial infections are a major cause of death in hospitals and healthcare settings. Bacteria can enter the body through wounds and surgery sites, ventilators and catheters, leading to pneumonia, urinary tract, abdominal and bloodstream infections. The Global Antibiotic Research and Development Partnership (GARDP) is working to develop new treatments for these serious bacterial infections, focusing on treatments for drug-resistant bacteria on the World Health Organization’s (WHO) priority pathogens list.

more_horiz
Sectors:

  • Medical research

Participating Organisations

Global Antibiotic Research and Development Partnership Public Private Partnership Implementing
German Federal Ministry of Education and Research Government Funding
Japanese Ministry of Health, Labour & Welfare Government Funding
UK - Department of Health and Social Care (DHSC) Government Funding
Federal Office of Public Health Government Funding
South African Medical Research Council Other Public Sector Funding

Transaction

Transaction Value Provider
Receiver 		Type Date
11,036 EUR South African Medical Research Council GARDP Expenditure
date_range Dec 31, 2022
3,633 EUR South African Medical Research Council GARDP Expenditure
date_range Dec 31, 2022
21,915 EUR South African Medical Research Council GARDP Expenditure
date_range Dec 31, 2022
7 EUR Federal Office of Public Health GARDP Expenditure
date_range Dec 31, 2022
78,551 EUR Japanese Ministry of Health, Labour and Welfare GARDP Expenditure
date_range Dec 31, 2022
1,351,140 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
137,934 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
80,646 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
27,171 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
63,174 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
40,016 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
640,651 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2022
5 EUR Australian Department of Health GARDP Expenditure
date_range Dec 31, 2022
111,569 EUR Japanese Ministry of Health, Labour and Welfare GARDP Expenditure
date_range Dec 31, 2021
17,385 EUR Japanese Ministry of Health, Labour and Welfare GARDP Expenditure
date_range Dec 31, 2021
8,343 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2021
24,236 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2021
46,803 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2021
152,951 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2021
421,632 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Dec 31, 2021
20,164 EUR South African Medical Research Council GARDP Expenditure
date_range Dec 31, 2021
9,119 EUR South African Medical Research Council GARDP Expenditure
date_range Dec 31, 2021
23,339 EUR German Federal Ministry of Education & Research GARDP Expenditure
date_range Nov 30, 2021
42 EUR Federal Office of Public Health GARDP Expenditure
date_range Oct 31, 2021
3,448 EUR South African Medical Research Council GARDP Expenditure
date_range Sep 30, 2021
114,843 EUR Department of Health and Social Care GARDP Expenditure
date_range Mar 31, 2021
1,847 EUR Department of Health and Social Care GARDP Expenditure
date_range Feb 28, 2021

Budget

0 USD
access_time Updated on Dec 12, 2023 11:10:25